CDKN2D anticorps
CDKN2D
Reactivité: Humain
WB, IF/ICC
Hôte: Lapin
Polyclonal
unconjugated
N° du produit ABIN2969501
-
-
Antigène
Voir toutes CDKN2D Anticorps
-
CDKN2D
(Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))
-
Reactivité
-
Humain
-
Hôte
-
Lapin
-
Clonalité
-
Polyclonal
-
Conjugué
-
Cet anticorp CDKN2D est non-conjugé
-
Application
-
Western Blotting (WB), Immunofluorescence (fixed cells) (IF/ICC)
-
Purification
-
Affinity purified
-
Immunogène
-
Recombinant protein of human CDKN2D.
-
Isotype
-
IgG
-
Top Product
-
Discover our top product CDKN2D Anticorps primaire
-
-
-
Indications d'application
-
Optimal working dilution should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Concentration
-
Lot specific
-
Buffer
-
PBS, pH 7.3, 0.02 % sodium azide, 50 % glycerol.
-
Agent conservateur
-
Sodium azide
-
Précaution d'utilisation
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
-
-20 °C
-
Stockage commentaire
-
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
Antigène
-
CDKN2D
(Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))
-
Autre désignation
-
CDKN2D (CDKN2D Produits)
-
Synonymes
-
anticorps ink4d, anticorps p19, anticorps p19-ink4d, anticorps CDKN2D, anticorps ank2, anticorps INK4D, anticorps p19-INK4D, anticorps INK4d, anticorps p19INK4d, anticorps cyclin-dependent kinase inhibitor 2D S homeolog, anticorps cyclin dependent kinase inhibitor 2D, anticorps cyclin-dependent kinase inhibitor 2D, anticorps Cyclin-dependent kinase 4 inhibitor D, anticorps cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4), anticorps similar to cyclin-dependent kinase inhibitor 2D, anticorps cdkn2d.S, anticorps CDKN2D, anticorps cdkn2d, anticorps cdn2d, anticorps Cdkn2d
-
Poids moléculaire
-
Calculated MW: 17 kDa
Observed MW: Refer to figures
-
ID gène
-
1032
-
UniProt
-
P55273
-
Pathways
-
Cycle Cellulaire, Sensory Perception of Sound, Mitotic G1-G1/S Phases, Negative Regulation of intrinsic apoptotic Signaling
-